Ceftriaxone 2g powder for solution for injection vials
NHS hospitals in England used £16,587,439 of indicative cost of Ceftriaxone 2g powder for solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 4.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ceftriaxone 2g powder for solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ceftriaxone 2g powder for solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Imperial College Healthcare Nhs Trust | £798,799 |
| Western Sussex Hospitals Nhs Found Trust | £625,249 |
| Royal Free London Nhs Foundation Trust | £445,869 |
| Croydon Health Services Nhs Trust | £419,581 |
| Chelsea & Westminster Hospital Nhs Ft | £409,971 |
| Barkinghavering & Redbridge Hpls Trst | £372,597 |
| Salford Royal Nhs Foundation Trust | £361,573 |
| Barts Health Nhs Trust | £328,265 |
| Univ Hpl B/Ham Nhs Foundation Trust | £326,312 |
| South Tees Hosp Nhs Foundation Trust | £313,531 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.